Recombinant proteins produced into yolk of genetically manipulated chickens are partly sialylated in N-glycan

Abstract The transgenic chicken is a candidate for the production of biopharmaceutical proteins with several economic superiorities. In general, the addition of sialic acid at the terminal of N-glycan is important for the bioactivity of biopharmaceuticals including plasma half-life; however, sialic...
Ausführliche Beschreibung

Gespeichert in:
Autor*in:

Yoshida, Kazuhiro [verfasserIn]

Okuzaki, Yuya [verfasserIn]

Nishijima, Ken-ichi [verfasserIn]

Kyogoku, Kenji [verfasserIn]

Yamashita, Takashi [verfasserIn]

Kawabe, Yoshinori [verfasserIn]

Motono, Makoto [verfasserIn]

Kamihira, Masamichi [verfasserIn]

Iijima, Shinji [verfasserIn]

Format:

E-Artikel

Sprache:

Englisch

Erschienen:

2013

Schlagwörter:

Genetically manipulated chicken

Glycosylation

Transgenic avian bioreactor

Pharmaceutical protein

Yolk transport

Übergeordnetes Werk:

Enthalten in: Cytotechnology - Dordrecht [u.a.] : Springer Science + Business Media B.V., 1987, 65(2013), 6 vom: 19. Juli, Seite 985-992

Übergeordnetes Werk:

volume:65 ; year:2013 ; number:6 ; day:19 ; month:07 ; pages:985-992

Links:

Volltext

DOI / URN:

10.1007/s10616-013-9613-z

Katalog-ID:

SPR011796189

Nicht das Richtige dabei?

Schreiben Sie uns!